Bristol Myers Squibb agreed to buy schizophrenia drug maker Karuna Therapeutics in a $14 billion deal.
Share:
More In Business
How Babylist Is Changing the Way You Get Ready for That Newest Family Member
Babylist CEO Natalie Gordon joins Cheddar to discuss how the website is helping new parents, how to make a registry and how secondhand options are available.
Biotechnology company Regeneron buying 23andMe for $256 million
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.
New York ends paper routes for younger kids
New York's recently approved budget makes clear that paper routes are not allowed for anyone under 14 years old.
From Viral Moments to Vital Conversations: Rachel Lindsay & Van Lathan On 'Higher Learning'
Celebrating 5 years of the hit podcast 'Higher Learning' with hosts Rachel Lindsay and Van Lathan on the floor of the New York Stock Exchange. Watch!
Returns, Reimagined: How ReturnPro Uses Smart Tech to Simplify Send-Backs
ReturnPro CEO Sender Shamiss to discuss how his company is changing the way we make returns and how Trump's tariffs are affecting the return business. Watch!
Big Business This Week: Big Blue gets bigger, without the blues
IBM is up 20% this year, thanks to AI consulting. Plus: UnitedHealthCare, Boeing, FedEx, Apple, Nissan, Dick's, Burberry, and HBO (Max). Whew!
Walmart warns “higher prices are inevitable”
Walmart, which became the nation’s largest retailer by making low prices a priority, has found itself in a place it’s rarely been: Warning customers that prices will rise for goods ranging from bananas to car seats.
U.S.–China Trade Truce: What It Means and What Comes Next
Chris Beauchamp, Chief Market Analyst at IG International, joins J.D. Durkin to give analysis on the recent trade truce between the U.S. and China. Watch!
Microsoft lays off about 3% of its staff on ‘day with a lot of tears’
Microsoft began laying off about 6,000 workers Tuesday, nearly 3% of its entire workforce and its largest job cuts in more than two years.
